The primate lentivirus auxiliary protein Vpx counteracts an unknown restriction factor that renders human dendritic and myeloid cells largely refractory to HIV-1 infection [1] [2] [3] [4] [5] [6] . Here we identify SAMHD1 as this restriction factor. SAMHD1 is a protein involved in Aicardi-Goutières syndrome, a genetic encephalopathy with symptoms mimicking congenital viral infection, that has been proposed to act as a negative regulator of the interferon response 7 . We show that Vpx induces proteasomal degradation of SAMHD1. Silencing of SAMHD1 in non-permissive cell lines alleviates HIV-1 restriction and is associated with a significant accumulation of viral DNA in infected cells. Concurrently, overexpression of SAMHD1 in sensitive cells inhibits HIV-1 infection. The putative phosphohydrolase activity of SAMHD1 is probably required for HIV-1 restriction. Vpx-mediated relief of restriction is abolished in SAMHD1-negative cells. Finally, silencing of SAMHD1 markedly increases the susceptibility of monocytic-derived dendritic cells to infection. Our results demonstrate that SAMHD1 is an antiretroviral protein expressed in cells of the myeloid lineage that inhibits an early step of the viral life cycle.
Most monocytic cell lines fail to recapitulate the HIV-1 restriction phenotype that is witnessed in primary dendritic cells and to a lesser extent in macrophages. One exception is represented by phorbol 12-myristate 13-acetate (PMA)-differentiated THP-1 monocytic cells 1, 2, [4] [5] [6] . Transduction of differentiated THP-1 cells by virus-like particles containing Vpx (VLP-Vpx) has been shown to increase their permissiveness to HIV-1 infection 1 . To identify the restriction factor targeted by Vpx, we generated a stable THP-1 cell line expressing Flag-HA epitopetagged Vpx mac251 from sooty mangabey (THP-1-Vpx). As expected, THP-1-Vpx cells were 17-fold more permissive to HIV-1 infection than parental cells when exposed to a vesicular stomatitis virus G protein (G)-pseudotyped HIV-1 with the luciferase gene in place of nef (HIV-LUC-G) (Supplementary Fig. 1 ). After differentiation, extracts were prepared from THP-1 and THP-1-Vpx cells. Flag-HA-Vpx mac251 (F/H-Vpx) was purified using tandem affinity chromatography 8 . Purified Vpx mac251 -associated proteins were resolved by SDS-polyacrylamide gel electrophoresis (PAGE) and silver stained (Fig. 1a) . The eluates were further analysed by mass spectrometry to allow for the identification of cellular partners that engage with Vpx mac251 in non-permissive cells. Previously described Vpx mac251 interactants were recovered, including the DDB1-CUL4-DCAF E3 ligase complex 9, 10 , confirming the validity of our approach. The SAM-and HD-domain-containing protein SAMHD1 was identified as a major Vpx mac251 -interacting protein (Table 1) . SAMHD1 was initially isolated as an interferon (IFN)-c-induced factor in macrophages and dendritic cells 11, 12 for which a function in innate immunity has been suggested 7, 13 . Furthermore, mutations in SAMHD1 have been shown to be responsible for 5% of Aicardi-Goutières syndrome cases, a genetically heterogeneous disorder characterized by inappropriate activation of the immune system and aberrant IFN-a secretion, symptoms reminiscent of congenital infection 7 .
The interaction of SAMHD1 with Vpx mac251 was confirmed by Flag-immunoprecipitation of F/H-Vpx and western blot analysis using a SAMHD1-specific antibody (Fig. 1b) . Notably, analysis of a, SIV mac251 Vpx was tandem-affinity-purified from Flag-and HA-tagged Vpx mac251 (F/H-Vpx)-expressing THP-1 cells (THP-1-Vpx) and peptideeluted under native conditions. Eluates were separated on SDS-PAGE and silver stained. SAMHD1 and major, previously described, Vpx mac251 interactants identified using tandem mass spectrometry are indicated (MW, protein molecular weight marker in kDa). b, Whole-cell extract (WCE) and Flag-immunoprecipitated F/H-Vpx analysis by western blot against DDB1, CUL4A and SAMHD1. c, THP-1 cells were treated with 50 mM MG132 for 2 h before a 2-h incubation with Vpx mac251 containing virus-like particles (VLPVpx). After a further overnight incubation with MG132, whole-cell extracts were prepared and analysed by western blot with the indicated antibodies. R.S.I., relative signal intensity. d, Analysis of the expression profile of SAMHD1 in different cell types by western blot. e, THP-1 cells were transduced with a bicistronic retroviral vector allowing expression of Vpx mac251 , Vpx ROD , Vpx RCM-NG and Vpx RCM-GAB and a selectable marker. After cell sorting and whole-cell extraction, the ability of Vpx variants to degrade SAMHD1 in THP-1 whole-cell extract was analysed by western blot using the indicated antibodies.
whole-cell extracts of THP-1-Vpx as compared to THP-1 reveals that expression of Vpx mac251 correlates with lower expression levels of SAMHD1 (Fig. 1b) . Transient delivery of Vpx mac251 into THP-1 cells through VLP-Vpx exposure caused a marked decrease in SAMHD1 levels in THP-1 cells (Fig. 1c) . Moreover, treatment of cells with the proteasome inhibitor MG132 restored SAMHD1 protein levels (Fig. 1c) , strongly suggesting that Vpx mac251 induces proteasomal degradation of SAMHD1. Additionally, when SAMHD1 was expressed in HeLa cells, Vpx also caused its degradation, demonstrating that Vpx-induced degradation of SAMHD1 is not a cell-typespecific process and excluding a potential transcriptional effect of Vpx on SAMHD1 ( Supplementary Fig. 2 ). These results led us to postulate that SAMHD1 may be the restriction factor that renders dendritic cells refractory to HIV-1 infection. Consistently, SAMHD1 is highly expressed in HIV-1 non-permissive cells such as THP-1, monocytes and monocyte-derived dendritic cells (MDDCs), whereas it is absent from HIV-1-sensitive T-cell lines such as Jurkat, SupT1, human peripheral blood acute lymphoid leukaemia (HPB-ALL) and U937 ( Fig. 1d ). In correlation with their degree of permissiveness to HIV-1 (refs 1, 4), monocyte-derived macrophages (MDMs) express low levels of SAMHD1 as compared to their highly refractory monocyte precursor (Fig. 1d) . It has been reported that Vpx-mediated enhancement of HIV-1 infection in dendritic cells and myeloid cells is conserved exclusively within the SIV SM (sooty mangabey) and HIV-2 lineage (refs 1, 2 and Supplementary Fig. 2a ). Concurrent with this observation, we show that Vpx mac251 and HIV-2 ROD Vpx (Vpx ROD ) both caused degradation of SAMHD1, whereas Vpx from SIV RCM of red-capped mangabeys (isolates of Nigerian (Vpx RCM-NG ) or Gabonese (Vpx RCM-GAB ) origin) failed to degrade SAMHD1 when expressed in THP-1 ( Fig. 1e and Supplementary Fig. 3a , b) or HeLa cells ( Supplementary Fig. 3c ). Additionally, loss-of-function mutants Vpx(Q76A) and Vpx(F80A) also failed to degrade SAMHD1in differentiated THP-1 cells (Supplementary Fig. 3d ).
To assess directly the impact of expression of SAMHD1 on HIV-1 infection, we used short hairpin RNAs (shRNA) to generate SAMHD1-silent THP-1 cells (THP-1-shSAMHD1) or scrambled shRNA (THP-1-scr) ( Supplementary Fig. 4 ). Infection of THP-1-shSAMHD1 cells with HIV-LUC-G results in up to a 12-fold increase in luciferase activity as compared to THP-1-scr cells, demonstrating that depletion of SAMHD1 is sufficient to increase the permissiveness of THP-1 cells to HIV-1 infection (Fig. 2a) . As expected, HIV-1 infection of THP-1-shSAMHD1 cells was not further enhanced by treatment with VLPVpx ( Fig. 2b and Supplementary Fig. 5 ). Importantly, expression of a shRNA-resistant SAMHD1 mutant (SAMHD1-R) in THP-1-shSAMHD1 cells restored the restriction phenotype in these cells ( Fig. 2d and Supplementary Fig. 6 ). To investigate further whether SAMHD1 possesses an intrinsic restriction activity targeting HIV-1, we stably expressed Flag-HA-tagged SAMHD1 (SAMHD1-F/H) in permissive U937 monocytic cells (U937-SAMHD1). Differentiated U937-SAMHD1 cells were 16-fold less permissive to infection with HIV-LUC-G than parental cells (Fig. 2e and Supplementary Fig. 8 ). HD domains have an important role in nucleotide metabolism through their nucleotidase and phosphodiesterase activities, where H and D residues are of crucial importance 14 . Interestingly, U937 cells stably expressing the SAMHD1(HD/AA) (U937-SAMHD1(HD/AA)) mutant did not show restriction activity towards HIV-1 as compared to U937-SAMHD1 cells, indicating that the putative phosphohydrolase activity of SAMHD1 may be required for restriction of HIV-1 LETTER RESEARCH (Fig. 2e and Supplementary Figs 7 and 8) . Additionally, transient expression of SAMHD1-F/H, but not SAMHD1(HD/AA), in permissive HeLa cells induced restriction of HIV-1 infection ( Supplementary  Fig. 7) .
Vpx has been shown to facilitate HIV-1 replication by promoting accumulation of viral DNA 1, 2, 4, 5, 15 . To investigate at which step of the viral replication cycle SAMHD1-dependent restriction operates, we quantified total viral DNA species 24 h after infection of THP-1-shSAMHD1 cells (Fig. 2f) . A 13-fold accumulation of total viral DNA was observed in SAMHD1-silenced cells as compared to their THP-1-scr counterpart. This observation locates the restriction operated by SAMHD1 at the reverse transcription step, which has been previously described to be overcome by Vpx in dendritic and myeloid cells 2 . Exposure of differentiated THP-1, MDDCs and MDMs to VLPVpx relieves restriction to HIV-1 infection (Fig. 3a and Supplementary Fig. 9 ) and correlates with a decrease in SAMHD1 levels ( Fig. 3b and Supplementary Fig. 9 ). Lower basal levels of SAMHD1 in primary MDMs (Fig. 1d ) may be accountable for the weaker impact of VLPVpx treatment of these cells ( Supplementary Fig. 9 ). Next, we asked whether SAMHD1 restricts HIV-1 infection of primary human dendritic cells. Immature MDDCs were prepared from the blood of four healthy donors. To silence SAMHD1 expression, we treated MDDCs with two different SAMHD1-specific siRNAs (si-SAMHD1-1 or si-SAMHD1-2). Scrambled or siRNA targeting dynamin 2 (siDYN2) were used as controls ( Fig. 3c and Supplementary Fig. 10 ).
MDDCs were transduced (at 48 h after silencing) with green-fluorescentprotein-or luciferase-encoding lentiviral vectors (LV-GFP or LV-LUC, respectively) or with a VSV-G-pseudotyped HIV (HIV-G).
Silencing of SAMHD1 resulted in up to a 6-fold increase of GFP-positive cells with LV-GFP, 25-fold enhanced luciferase activity with LV-LUC, and up to 34-fold increased Gag-positive cells with HIV-G (Fig. 3d-f and Supplementary Fig. 10 ), demonstrating that SAMHD1 silencing in dendritic cells enhances their susceptibility to HIV-1 infection.
So far, three restriction factors (TRIM5a, APOBEC-3G and tetherin) have been identified that could have constituted a major hindrance to HIV-1 replication, had the virus not developed ways to counteract or to escape their action [16] [17] [18] . These restriction factors are part of the intrinsic immunity that is circumvented by HIV-1 mainly through the action of its auxiliary proteins. However, the cell-typespecific restriction factor SAMHD1 is not counteracted by HIV-1, resulting in poorly efficient replication in dendritic cells. Indeed, in the normal course of HIV-1 infection and because dendritic cells are non-permissive, these cells rather facilitate viral dissemination through trans-enhancement of infection, eventually favouring CD4 1 T-cell depletion 19, 20 . Poor HIV-1 replication in dendritic cells may also allow for avoidance of a recently described cryptic viral sensor that would otherwise elicit antiviral interferon-induced immune responses 20, 21 . Similarly, in productively infected CD4
1 T cells, through the action of the cellular DNase TREX1, HIV-1 avoids the induction of type 1 IFN production that could result from accumulation of viral DNA 20, 22 . Of note, both TREX1 and SAMHD1 deficiencies lead to Aicardi-Goutières syndrome, indicating that they have an impact on the same pathway of cell-intrinsic antiviral response 7 . SAMHD1, through the putative nucleotidase activity, may degrade or prevent accumulation of HIV DNA. It will be worth determining further the relative roles of TREX1 and SAMHD1 in the control of virus infection and in the triggering of innate antiviral and inflammatory responses.
Our findings position SAMHD1 as pivotal to the fate of infection by HIV-1 in cells of the myeloid lineage. Thus, modulating SAMHD1 function could render human hosts more prone to develop appropriate innate and adaptive immune responses 19, [22] [23] [24] . Our findings should be integrated in the development of dendritic-cell-targeted vaccines against HIV/AIDS. 
RESEARCH LETTER METHODS SUMMARY
Vpx mac251 was purified from 5 3 10 9 differentiated THP-1 cells stably expressing Flag-and HA-tagged Vpx mac251 (F/H-Vpx) by two-step affinity chromatography according to the standard method 8 . Extracts were first incubated with anti-Flag antibody conjugated agarose beads and the bound polypeptides were eluted with Flag peptide under native conditions. The Flag affinity-purified material was further immunopurified by affinity chromatography using anti-HA antibodyconjugated agarose beads and eluted under native conditions using HA peptide. Five per cent of immunoaffinity-purified F/H-Vpx or mock were resolved on SDS-PAGE and silver stained while the remainder was stained with Coomassie-R250. Regions of the gel were excised and subsequently analysed by tandem mass spectrometry. U937 and THP-1 cells were differentiated overnight with 30 ng ml 21 PMA before all infections. MDDCs and MDMs were prepared from human buffy coats of healthy donors. Silencing of SAMHD1 in THP-1 and in MDDCs 25 was achieved by selecting cells stably expressing shRNA or using siRNA targeting SAMHD1. All experiments were repeated at least four times.
METHODS
Cell lines. Adherent and suspension cells were cultured in DMEM or RPMI supplemented with 10% fetal calf serum (FCS), ultraglutamine and antibiotics. All cell culture reagents were purchased from Lonza. Cell lines expressing Flagand HA-tagged proteins were constructed using the previously described MMLVbased retroviral constructs 8, 26 that contain a bicistronic transcriptional unit allowing for expression of a selectable marker (IL-2 receptor-a chain (pOZIL2Ra) or puromycin resistance gene (pOZ-puro)). IL2Ra-selected cell lines were selected using magnetic beads. Puromycin-selected cell lines were cultured in appropriate media supplemented with 1 mg ml 21 puromycin. shRNA-silenced cell lines were generated according to the manufacturer's instructions (Openbiosystem) and selected for resistance to puromycin. U937 and THP-1 cells were differentiated overnight with 30 ng ml 21 PMA (Sigma). Plasmids. SIV3
1 was a gift from N. Manel. HIV-LUC, VSV-G, MMLV packaging and A-MLV envelope have been previously described 27 . shRNA constructs were purchased from Openbiosystem. Vpx ROD , Vpx RCM-NG and Vpx RCM-GAB were synthesized by MWG biotech. The SAMHD1 molecular clone was purchased from Invitrogen. All Vpx mac251 , Vpx ROD , Vpx RCM-NG and Vpx RCM-GAB were subcloned in pOZ-IL2Ra expression vector with tags at the N terminus, and SAMHD1 and SAMHD1 mutants were subcloned in pOZ-puro expression vector with tags at the C terminus according to standard ligation procedures. SAMHD1(HD/AA) and SAMHD1-R mutants were generated using the Quickchange lightning kit (Agilent technologies) according the manufacturer's recommendations. Virus production. Viral particles were produced from 293T cells using the standard phosphate calcium transfection protocol. Briefly, for HIV-LUC-G production, 293T cells were transfected with 8 mg HIV-LUC and 2 mg VSV-G encoding plasmid; for shRNA production, 293T cells were transfected with 4 mg shRNA construct, 4 mg packaging plasmid, 2 mg VSV-G encoding plasmid; for MLV transduction particles, 293T cells were transfected with 5 mg pOZ construct, 2.5 mg packaging plasmid and 2.5 mg A-MLV envelope encoding plasmid; and for VLP-Vpx production, 8 mg SIV3
1 was co-transfected or not with 2 mg VSV-G encoding plasmid. Media was replaced 16 h after transfection and viruses were harvested 24 h later, filtered at 0.45 mm. When required, p24 concentration was measured by ELISA (Innogenetics). Infection. Infection of THP-1, U937 and HeLa cells was performed by addition of 100, 50, 10, 5 or 1 ng p24 of HIV-LUC-G depending on the experiment. Viruses were added to cells and luciferase activity was measured 24 h after infection. VLPVpx treatment was performed for 2 h before infection by addition of RPMI-diluted VLP-Vpx to cells. Cell extract preparation and western blot analysis. Whole-cell extracts were prepared with buffer containing 0.5% Triton X-100, 150 mM NaCl, 10 mM KCL, 1.5 mM MgCl 2 , 0.5 mM EDTA 10 mM b-mercaptoethanol, 0.5 mM PMSF. Mouse anti-SAMHD1, anti-CUL4A and anti-DDB1 were purchased from Abcam. HA (11 clone 16B12) and tubulin antibodies were from Covance/Eurogentec and Sigma, respectively. Immunopurification. Vpx mac251 was purified from 5 3 10 9 differentiated THP-1 cells stably expressing Flag-and HA-tagged Vpx mac251 (F/H-Vpx) by two-step affinity chromatography according to the standard method 8 . Extracts were first incubated with anti-Flag antibody conjugated agarose beads (Sigma), and the bound polypeptides were eluted with Flag peptide (Sigma) under native conditions. The Flag affinity-purified material was further immunopurified by affinity chromatography using anti-HA antibody conjugated agarose beads (Santa Cruz) and eluted under native conditions using HA peptide (Roche). Five per cent of immunoaffinity-purified F/H-Vpx or mock were resolved on SDS-PAGE and stained with the Silverquest kit (Invitrogen). The remainder of the eluate was stained with colloidal blue. Individual Coomassie-stained bands, or for closely migrating bands, regions of the gel were excised and subsequently analysed by tandem mass spectrometry at the Harvard Medical School Taplin Biological Mass Spectrometry facility. Quantification of HIV-1 total DNA. Before infection, viral stocks were treated for 1 h at 37 uC with 100 U ml 21 of DNaseI (Roche). 3 3 10 5 THP-1-scr or THP-1-shSAMHD1 cells were infected with 100 ng of HIV-LUC-G or with heat-inactivated HIV-LUC-G. Cells were washed twice in PBS 2 h after infection, harvested 22 h later, washed twice in PBS, and DNA was extracted using the QIAamp Blood DNA Minikit (Qiagen). Quantification of viral DNA was performed by quantitative PCR (qPCR) using previously described probes 27 allowing for amplification of the luciferase gene on a LightCycler 480 system (Roche). Viral DNA was normalized using 7SK-specific probes. Preparation of MDDCs and MDMs. Human buffy coats were obtained from Etablissement Français du Sang (EFS). Monocytes were purified from total peripheral blood mononuclear cells after Ficoll gradient separation with CD14 MicroBeads (Miltenyi Biotec) or using the standard adhesion protocol. Human monocyte-derived dendritic cells (MDDCs) were generated by incubation of CD14 purified monocytes in IMDM medium supplemented with 10% FCS, 2 mM L-glutamine, 100 IU ml 21 penicillin, 100 mg ml 21 streptomycin, 10 mM HEPES, 1% non-essential amino acids, 1 mM sodium pyruvate, 10 ng ml 21 
